BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30460461)

  • 1. Exploring the binding properties of agonists interacting with glucocorticoid receptor: an in silico approach.
    Rathnayake S; Weerasinghe S
    J Mol Model; 2018 Nov; 24(12):342. PubMed ID: 30460461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation on critical structural motifs of ligands for triggering glucocorticoid receptor nuclear migration through molecular docking simulations.
    Liu YL; Jang S; Wang SM; Chen CH; Li FY
    J Biomol Struct Dyn; 2016 Jun; 34(6):1214-31. PubMed ID: 26198481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First High-Resolution Crystal Structures of the Glucocorticoid Receptor Ligand-Binding Domain-Peroxisome Proliferator-Activated
    Liu X; Wang Y; Ortlund EA
    Mol Pharmacol; 2019 Oct; 96(4):408-417. PubMed ID: 31391291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Insights into the Ligand Binding Domain of the Glucocorticoid Receptor: A Molecular Dynamics Study.
    Alves NRC; Pecci A; Alvarez LD
    J Chem Inf Model; 2020 Feb; 60(2):794-804. PubMed ID: 31689103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures and mechanism for the design of highly potent glucocorticoids.
    He Y; Yi W; Suino-Powell K; Zhou XE; Tolbert WD; Tang X; Yang J; Yang H; Shi J; Hou L; Jiang H; Melcher K; Xu HE
    Cell Res; 2014 Jun; 24(6):713-26. PubMed ID: 24763108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Glucocorticoid Receptor Binding and Agonist Activities of Typical Glucocorticoids: Insights into Their Endocrine Disrupting Effects.
    Liang Y; Li Z; Zhang J; Li T; Lv C
    Chem Biodivers; 2024 Feb; 21(2):e202301525. PubMed ID: 38129310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
    Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
    Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unbinding pathways from the glucocorticoid receptor shed light on the reduced sensitivity of glucocorticoid ligands to a naturally occurring, clinically relevant mutant receptor.
    Capelli AM; Bruno A; Entrena Guadix A; Costantino G
    J Med Chem; 2013 Sep; 56(17):7003-14. PubMed ID: 23927519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of glucocorticoid receptor differentially affect AF2 domain activity in a steroid-selective manner to alter the potency and efficacy of gene induction and repression.
    Tao YG; Xu Y; Xu HE; Simons SS
    Biochemistry; 2008 Jul; 47(29):7648-62. PubMed ID: 18578507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct interaction of cortivazol with the ligand binding domain confers glucocorticoid receptor specificity: cortivazol is a specific ligand for the glucocorticoid receptor.
    Yoshikawa N; Makino Y; Okamoto K; Morimoto C; Makino I; Tanaka H
    J Biol Chem; 2002 Feb; 277(7):5529-40. PubMed ID: 11741935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes.
    Cho S; Blackford JA; Simons SS
    Biochemistry; 2005 Mar; 44(9):3547-61. PubMed ID: 15736964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural determinants of cortisol resistance in the guinea pig glucocorticoid receptor.
    Keightley MC; Curtis AJ; Chu S; Fuller PJ
    Endocrinology; 1998 May; 139(5):2479-85. PubMed ID: 9564861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid receptor interactions with glucocorticoids: evaluation by molecular modeling and functional analysis of glucocorticoid receptor mutants.
    Hammer S; Spika I; Sippl W; Jessen G; Kleuser B; Höltje HD; Schäfer-Korting M
    Steroids; 2003 Apr; 68(4):329-39. PubMed ID: 12787894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking and dynamic simulation approach to decipher steroidal sapogenins (genus
    Suresh PS; Thakur KG; Sharma U
    J Biomol Struct Dyn; 2023 Jan; 41(1):55-66. PubMed ID: 34825633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand binding domain mutations of the glucocorticoid receptor selectively modify the effects with, but not binding of, cofactors.
    Lee GS; Simons SS
    Biochemistry; 2011 Jan; 50(3):356-66. PubMed ID: 21142156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Natural Mutation in Helix 5 of the Ligand Binding Domain of Glucocorticoid Receptor Enhances Receptor-Ligand Interaction.
    Reyer H; Ponsuksili S; Kanitz E; Pöhland R; Wimmers K; Murani E
    PLoS One; 2016; 11(10):e0164628. PubMed ID: 27736993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of boswellic acids with the ligand binding domain of the glucocorticoid receptor.
    Scior T; Verhoff M; Gutierrez-Aztatzi I; Ammon HP; Laufer S; Werz O
    J Chem Inf Model; 2014 Mar; 54(3):978-86. PubMed ID: 24512031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Analysis of the Glucocorticoid Receptor Ligand-Binding Domain in Complex with Triamcinolone Acetonide and a Fragment of the Atypical Coregulator, Small Heterodimer Partner.
    Weikum ER; Okafor CD; D'Agostino EH; Colucci JK; Ortlund EA
    Mol Pharmacol; 2017 Jul; 92(1):12-21. PubMed ID: 28396564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of the interaction specificity between the human glucocorticoid receptor and its endogenous steroid ligand cortisol.
    von Langen J; Fritzemeier KH; Diekmann S; Hillisch A
    Chembiochem; 2005 Jun; 6(6):1110-8. PubMed ID: 15883974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering the structural basis for glucocorticoid resistance caused by missense mutations in the ligand binding domain of glucocorticoid receptor.
    Monteiro LLS; Franco OL; Alencar SA; Porto WF
    J Mol Graph Model; 2019 Nov; 92():216-226. PubMed ID: 31401440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.